US 11478511
Lymphocyte biomarkers for determining the clinical response to cell therapy
granted A61KA61K2239/31A61K2239/38
Quick answer
US patent 11478511 (Lymphocyte biomarkers for determining the clinical response to cell therapy) held by Takeda Pharmaceutical Company Limited expires Mon Oct 20 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue Oct 25 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 20 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 16
- CPC classes
- A61K, A61K2239/31, A61K2239/38, A61K35/28, A61K35/33